Which breakthrough scientific product development approach significantly reduced time-to-market for COVID-19 vaccines compared to traditional vaccine development timelines?

Scientific advancements often face challenges transitioning from laboratory discoveries to consumer products. This poll explores the fascinating intersection of scientific innovation and retail product development, focusing on how breakthrough technologies move from research environments to commercial success. Test your knowledge about the product development lifecycle in science-based industries and the factors that influence successful commercialization of scientific discoveries.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

mRNA platform technology that allowed for rapid prototyping and manufacturing scale-up
Increased government funding for traditional attenuated virus vaccine production
Elimination of all clinical trial phases in the development process
Exclusive use of existing influenza vaccine production infrastructure